The use of patient registries for orphan drugs and rare diseases

被引:0
|
作者
Clarke, Joe T. R. [1 ]
Hernberg-Stahl, Elizabeth [2 ]
机构
[1] CHUS Hop Fleurimont, Serv Genet Med, Sherbrooke, PQ J1H 5N4, Canada
[2] Late Phase Solut Europe AB, Taby, Sweden
来源
EJHP PRACTICE | 2010年 / 16卷 / 04期
关键词
FABRY-DISEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [31] Rare diseases and orphan drugs: 500 years ago
    Dooms, Marc M.
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [32] Rare diseases and orphan drugs: 500 years ago
    Marc M. Dooms
    Orphanet Journal of Rare Diseases, 10
  • [33] The availability and affordability of orphan drugs for rare diseases in China
    Gong, Shiwei
    Wang, Yingxiao
    Pan, Xiaoyun
    Zhang, Liang
    Huang, Rui
    Chen, Xin
    Hu, Juanjuan
    Xu, Yi
    Jin, Si
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [34] Orphan Drugs for Rare Diseases: Grounds for Special Status
    Picavet, Eline
    Dooms, Marc
    Cassiman, David
    Simoens, Steven
    DRUG DEVELOPMENT RESEARCH, 2012, 73 (03) : 115 - 119
  • [35] Rare diseases and orphan drugs in Eastern European Countries
    Stefanov, Rumen
    Taruscio, Domenica
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2009, 6 (04): : 289 - 293
  • [36] Rare diseases, orphan drugs and their regulation: questions and misconceptions
    Erik Tambuyzer
    Nature Reviews Drug Discovery, 2010, 9 : 921 - 929
  • [37] Orphan drugs and orphan diseases
    Campos-Castelló, J
    REVISTA DE NEUROLOGIA, 2001, 33 (03) : 216 - 220
  • [38] Establishing Patient Registries for Rare Diseases: Rationale and Challenges
    Vanessa Boulanger
    Marissa Schlemmer
    Suzanne Rossov
    Allison Seebald
    Pamela Gavin
    Pharmaceutical Medicine, 2020, 34 : 185 - 190
  • [39] Establishing Patient Registries for Rare Diseases: Rationale and Challenges
    Boulanger, Vanessa
    Schlemmer, Marissa
    Rossov, Suzanne
    Seebald, Allison
    Gavin, Pamela
    PHARMACEUTICAL MEDICINE, 2020, 34 (03) : 185 - 190
  • [40] Framework for Multistakeholder Patient Registries in the Field of Rare Diseases
    Schoenmakers, Daphne H.
    van den Berg, Sibren
    Timmers, Lonneke
    Adang, Laura A.
    Baumer, Tobias
    Bosch, Annet
    van de Casteele, Marc
    Datema, Mareen R.
    Dekker, Hanka
    Donnelly, Conan
    Driessens, Mariette H. E.
    Graessner, Holm
    Greger, Valerie
    Haddad, Tala
    Hoglinger, Gunter U.
    van den Hout, Hannerieke
    Jonker, Carla
    Langeveld, Mirjam
    Lambert, Laurie J.
    Neacy, Eileen
    Nieuwland, Marc
    Klockgether, Thomas
    van der Knaap, Marjo S.
    Papadopoulou, Andri
    Plueschke, Kelly
    van Rijn, Sanne
    Rosenberg, Noa
    Saunier-Vivar, Elise F.
    Vieira, Bruna dos Santos
    Hollak, Carla E. M.
    Goettsch, Wim G.
    Wolf, Nicole I.
    NEUROLOGY, 2024, 103 (06)